The National Thoroughbred Racing Association announced that an updated set of racetrack safety and integrity standards has been approved by members of the NTRA Safety & Integrity Alliance Advisory Board and the NTRA board.
The first phase of an Ohio study into the effects the mineral cobalt has on horses showed that intravenous administration at high doses has detrimental effects on body systems.
The New York State Commission Nov. 23 proposed far-reaching equine drug rules as they slapped trainer Steve Asmussen with a $10,000 fine stemming from a probe into allegations of equine abuse brought against him by PETA.
State officials in Pennsylvania said they expect lawmakers the week of Nov. 16 to consider legislation that would, in part, stabilize the funding of horse racing regulation.
Standardbred racetrack owner Jeff Gural Nov. 12 said track owners should take the lead in improving integrity in the horseracing industry.
The New York State Gaming Commission has indefinitely suspended trainer Roy Sedlacek for two positives in October at Belmont Park for AH-7921, a synthetic opioid.
TOBA Nov. 2 said it will become a member of the Coalition for Horse Racing Integrity and support federal legislation that would allow USADA oversight over equine medication, drug testing, and enforcement.
Breeders' Cup has again expanded its welfare, safety, and integrity protocol for this year's World Championships, with a big assist from host track Keeneland.
The furosemide industry is a $3 million annual business for Thoroughbred racing in New York state, regulators said Oct. 26, with the average horse given $500 worth of doses in a typical year.
Host Lenny Shulman sits down with Breeders' Cup president and CEO Craig Fravel. Lenny also reflects on medication. Presented by Hill 'n' Dale Stallions watch video
The state of New York, citing costs savings, is considering a plan to halt a practice in which the state, at its expense, tests all claimed horses to check for the presence of drugs or other substances.
The California Horse Racing Board took steps toward new guidelines for medication violators, during its Oct. 22 meeting at Santa Anita Park that would prevent those violators from transferring horses to their employees.
- By Tom LaMarra
- Horse Health, Northeast Region, Midwest Region, Southeast Region, Southwest Region, West Region, Kentucky, Mid-Atlantic Region
The RMTC, which met Oct. 13, cited progress in state-by-state adoption of components of the National Uniform Medication Program and also added four drugs to the list of controlled substances.
Six members of Congress have announced their support for the Thoroughbred Horseracing Integrity Act of 2015, according to the Coalition for Horse Racing Integrity.
The California Horse Racing Board Oct. 9 said limits on the amount of the trace element cobalt that can be detected in racehorses officially took effect Oct. 5.
Kent Stirling, who has served as executive director of the Florida Horsemen's Benevolent and Protective Association since 1995, will transition out of the position this year.
Keeneland said Oct. 8 it officially is in support of the Thoroughbred Horseracing Integrity Act of 2015 and has joined the Coalition for Horse Racing Integrity, a group that also supports the federal legislation.
The chairman of the International Federation of Horseracing Authorities, in an address Oct. 5 in Paris, France, outlined what he called matters that are critical to the future of racing on an international level.
- By Blood-Horse Staff
- Northeast Region, Midwest Region, Southeast Region, Southwest Region, West Region, Kentucky, Mid-Atlantic Region
ARCI Sept. 29 announced members of a committee that will work with regulators in each racing state to complete implementation of reforms that make up the National Uniform Medication Program.
The New York State Gaming Commission Sept. 24 passed several rule amendments related to equine medication, including further restrictions on the use of non-steroidal anti-inflammatory drugs and a total ban on stanozolol.
California Horse Racing Board commissioner George Krikorian's Big Book has been disqualified from her victory in the July 25 Fleet Treat at Del Mar because of a test that showed elevated levels of acepromazine.
A federally sanctioned medication program is racing's best hope for uniformity. read blog
A Thoroughbred Owners and Breeders Association committee has renewed talks regarding a proposal to phase out use of race-day furosemide in graded stakes.
In a survey designed to combat claims that the leaders of horsemen's groups don't represent their membership, the Florida HBPA Sept. 16 released the results of a poll that said most respondents support use of Lasix.
How would you handicap 'off-Lasix' horses?
The Association of Racing Commissioners International is stepping up efforts to get state regulators to fully adopt the National Uniform Medication Program.
Two research projects designed to study the impact of furosemide on exercise-induced pulmonary hemorrhage will be conducted on behalf of the Grayson-Jockey Club Research Foundation, the organization said Sept. 15.
The United States Anti-Doping Agency says it acted appropriately when allowing Floyd Mayweather to receive an intravenous injection before his May 2 fight with Manny Pacquiao.
The California Horse Racing Board Medication and Track Safety Committee took a step forward Sept. 4 regarding potential employment of third-party furosemide administration in the state.
The people who put their money on the line wagering on horse racing would like to see an overhaul of its drug testing and enforcement, based on results of a recent survey.
The Ohio State Racing Commission is moving forward with what it has called a comprehensive study into the effects of the mineral cobalt on racehorses.
The Indiana Horse Racing Commission said Aug. 31 that none of the 221 samples tested for cobalt during the first 60 days of the Indiana Grand Racing & Casino meet were above the published threshold level.
The New York Thoroughbred Horsemen's Association Sept. 1 said it will commit $450,000 to acquire state-of-the-art equipment for the New York Equine Drug Testing and Research Program at Morrisville State College.
The California Thoroughbred Trainers Aug. 31 said its leadership unanimously agreed to use $150,000 from reserve funds to facilitate race-day camera surveillance in barn areas at California racetracks.
The Louisiana State Racing Commission Aug. 24 adopted the Controlled Therapeutic Medication Schedule of 26 commonly used substances.
A new study funded by the USTA is designed to determine whether the naturally occurring mineral cobalt, when administered in larger, regular doses, has blood-doping qualities and could enhance performance.
The Coalition for Horse Racing Integrity said Aug. 21 California's failure to adopt third-party administration of the race-day drug furosemide shows the pitfalls of state-by-state regulation.
Use of race-day furosemide will be the topic for a daylong forum put together by the New York State Gaming Commission Aug. 25 in Saratoga Springs, N.Y.
A co-sponsor of federal legislation that would authorize oversight of equine medication and drug-testing said Congress could schedule a committee hearing on the bill this fall. Meanwhile, the debate on the bill continues.
The board of directors of the Thoroughbred Owners and Breeders Association Aug. 12 tackled the issue of whether to support the Thoroughbred Horseracing Integrity Act of 2015.
Bettors need to believe in the product
The opening panel Aug. 11 at the Saratoga Institute on Racing, Equine, and Gaming Law conference set the tone for what figures to be a continued industry battle over federal versus state-by-state regulation.
Do horse racing's current medication control programs stand up? read blog
Leroy Gessmann, president of the Iowa Horsemen's Benevolent and Protective Association, was elected president of the National HBPA Aug. 9 when the board of directors met as part of the organization's summer convention.
The Association of Racing Commissioners International the afternoon of Aug. 9 issued a strong response to comments made during The Jockey Club Round Table conference held earlier in the day in Saratoga Springs, N.Y.
State-by-state efforts to bring about uniformity in medication policies and drug testing aren't sufficient to move the Thoroughbred industry forward speakers said Aug. 9 at The Jockey Club Round Table conference.
The National Thoroughbred Racing Association will host a legislative briefing open to industry stakeholders and other interested parties at 2 p.m. PDT, Aug. 21 in the Del Mar Turf Club Director's Room.
Marc Summers, vice president and general counsel for The Jockey Club, has prepared a side-by-side comparison of two federal bills that propose creating a national program for managing medication use in racehorses.
When the National Horsemen's Benevolent and Protective Association meets Aug. 6-9 for its summer convention, equine medication will again be a major issue for the organization.
A recommendation by an attorney for Delaware racing stewards to drop a therapeutic medication overage case against trainer Todd Pletcher could impact the sport's move toward uniform medication rules, Pletcher's attorney said.
Most Popular Stories
- Seeking the Gold Dies at 31
- Little Mike Retired to Old Friends
- American Cleopatra Entered at Del Mar
- Borell Arraignment Set for Aug. 1
- Full Field Possible for West Virginia Derby
- Champion Tepin Will Bypass Fourstardave
- Connect Leads 1-2 Finish for Brown in Curlin
- Nyquist, Exaggerator Renew Rivalry in Haskell
- Sunday Silence Dominates Broodmare Sires
- Exaggerator to Run in Haskell